Clinical trial
Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin…
NCT00004311 · National Center for Research Resources (NCRR), NIH · Completed
Key facts
| NCT number | NCT00004311 |
|---|---|
| Title | Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | Baylor College of Medicine |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acanthosis Nigricans, Polycystic Ovary Syndrome |
| Intervention type | Drug |
| Interventions | leuprolide acetate, spironolactone |
| Start date | Jul 1, 1989 |
| Completion | Jan 1, 1996 |
| First posted | Oct 19, 1999 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: